Free Newsletter
Sancilio leads by example in U.S.-made drug rally
Pharma industry veteran Fred Sancilio is a yes-man when it comes to making drug products in the U.S. that compete with those made off-shore. He is currently is hiring workers, recruiting scientists and investing in his Riviera Beach, FL, manufacturing plant; he expects $6 million in sales this year, a six-fold increase over last year.
His approach is not completely on-shore, however. His plant includes a prefabricated cleanroom made in China but assembled in Florida. Likewise with some of his pharma manufacturing equipment. "If I'm starting with machines that are ten times more expensive, I can't compete because my depreciation is 10 times as high," said Sancilio, who in 1979 founded aaiPharma of Wilmington, NC. He has come out of retirement to champion made-in-America drugs.
"We're forgetting how to make stuff," says Sancilio in the Palm Beach Post. And we're putting ourselves at risk. Sancilio said his tours of drug plants in China have been scary. "I have no doubt that there'll be a huge disaster. We're fooling around with lives," he added.
- see the Post article
Related Articles:
Facilities demonstrate manufacturing demand
Plant design emphasizes green
API manufacturing gets makeovers
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: